For the first time, microplastics have been found in human ovarian follicular fluid, raising fears of their effect on women's fertility. The peer-reviewed study, published in Ecotoxicology and ...

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...

In this 3-year updated analysis, the ORR was 77.8%, with 60.0% of patients achieving a CR with mosunetuzumab. Updated results from the pivotal phase 1/2 trial of mosunetuzumab in patients with ...

Two clinical trials testing the antibody loncastuximab tesirine (Zynlonta) showed encouraging results in patients with high-risk forms of two blood cancers—follicular lymphoma and marginal zone ...

Objective: This study aimed to systematically investigate and compare the post-treatment recurrence of intraosseous ameloblastoma in patients treated with conservative or aggressive approaches.